Martin Ebner is co-founder and member of the Board of LamKap Bio group.
He founded the Swiss bank BZ Bank AG in 1985. As an active investor Martin Ebner is the largest shareholder in the listed Swiss companies Temenos and Intershop Holding AG. He was also the largest shareholder in Vifor Pharma, which was recently sold to CSL in a billion-dollar deal. He is the controlling shareholder of Helvetic Airways and Novimmune/Light Chain Bioscience.
The investments are under the roof of Patinex AG and Anna Holding AG and are managed by Patinex Management AG.
Martin Ebner earned a degree in law (lic.iur.) from the University of Zurich, Switzerland, and a PhD in Business Administration from the University of Florida, USA.
